Hawkins earnings release, July 29, 2026

Hawkins Inc (HWKN) · Form 8-K, Item 2.02 · Filed · SEC filing

Hawkins, Inc. Reports

First Quarter Fiscal 2027 Results

Roseville, Minn., July 29, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 28, 2026, its first quarter of fiscal 2027.

First Quarter Fiscal Year 2027 Highlights:

(All comparisons are to the first quarter of fiscal 2026 unless otherwise noted.)

• Record first quarter revenue of $315.7 million, with growth of 8%, driven by increased sales across all segments, including Water Treatment segment growth of 6%, Food & Health Sciences segment growth of 9%, and Industrial Solutions segment growth of 10%.

• Record first quarter gross profit of $74.0 million, an increase of 2%.

• Diluted earnings per share ("EPS") of $1.35 decreased $0.05, or 4%.

• Net income of $28.3 million decreased 3%, with trailing twelve-month net income of $80.6 million. Record Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure, of $56.9 million, a 1% increase. Trailing twelve-month adjusted EBITDA of $179.8 million.

• Generated operating cash flow of $35.2 million, an increase of 12%. Free cash flow, defined as net cash provided by operating activities less capital expenditures, increased over 30%, to $23.5 million, which we allocated to repurchasing $7.0 million of stock, paying $4.0 million in dividends, and acquiring Aqua-Chem, Inc. for $3.6 million.

• We continued to execute on our Water Treatment growth strategy with the purchase of Aqua-Chem, Inc., a distributor of water treatment products mainly in Nebraska and Iowa.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Our first quarter was a solid start to the year, highlighted by another quarter of record results in revenue, gross profit, and adjusted EBITDA” said Patrick Hawkins, Chief Executive Officer and President. “Our record revenue of $315.7 million was the result of all three reporting segments growing year over year, and included organic revenue growth of approximately 5%, consistent with our expectation of returning to historical organic revenue growth rates in fiscal 2027.”

Mr. Hawkins continued, “The first quarter brought raw material volatility. Our great team members stayed close to our suppliers and our customers, managing input costs while continuing to deliver the products and level of service expected from Hawkins. As we exited the quarter, raw material costs had largely stabilized.”

Mr. Hawkins concluded, “Our balance sheet remains strong, and our leverage ratio at the end of the first quarter was 1.36x adjusted EBITDA. We continue to generate strong free cash flow and we expect to continue to pay down debt during fiscal 2027. We will also continue to deliver on our strategy of investing in our higher-margin businesses, acquiring companies that are accretive to Hawkins, and servicing the needs of our customers to the highest level possible.”

First Quarter Financial Highlights:

NET INCOME

For the first quarter of fiscal 2027, we reported net income of $28.3 million, or $1.35 per diluted share, compared to net income for the first quarter of fiscal 2026 of $29.2 million, or $1.40 per diluted share.

REVENUE

Sales were $315.7 million for the first quarter of fiscal 2027, an increase of $22.4 million, or 8%, from sales of $293.3 million in the same period a year ago. All of our segments grew by more than 5% from the same period a year ago.

Water Treatment segment sales increased $8.7 million, or 6%, to $158.3 million for the current quarter, from $149.6 million in the same period a year ago. Water Treatment sales increased as a result of $6.9 million of added sales from acquired businesses, as well as increased organic sales volumes and improved pricing on certain products in our legacy business, including continued growth in our proprietary product lines.

Food & Health Sciences segment sales increased $8.1 million, or 9%, to $97.3 million for the current quarter, from $89.2 million in the same period a year ago. Sales of our agricultural, nutrition, and pharmaceutical products all increased over the same period a year ago, partially offset by decreased sales volumes of our food ingredient products. Agricultural products remained a source of strength, with sales growth of 30% driven by higher volumes.

Industrial Solutions segment sales increased $5.6 million, or 10%, to $60.1 million for the current quarter, from $54.5 million in the same period a year ago. Industrial Solutions segment sales increased primarily as a result of increased sales volumes of certain of our manufactured, blended and repackaged products.

GROSS PROFIT

Gross profit increased $1.6 million, or 2%, to $74.0 million, or 23% of sales, for the current quarter, from $72.4 million, or 25% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $1.9 million, a $1.3 million greater headwind than in the same period a year ago. In addition to the impact of the LIFO reserve, gross margin was pressured by higher freight costs of approximately $1.3 million that were not fully recovered through freight charges billed to customers.

Gross profit for the Water Treatment segment increased $1.7 million, or 4%, to $45.5 million, or 29% of sales, for the current quarter, from $43.7 million, or 29% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased by $0.5 million, a $0.3 million greater headwind than in the same period a year ago. The increase in gross profit was primarily driven by higher sales partially offset by higher LIFO and freight costs.... (truncated)es volumes was offset by higher LIFO and freight costs.

Gross profit for the Industrial Solutions segment of $9.2 million, or 15% of sales, for the current quarter, was relatively flat compared to $9.3 million, or 17% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million, a $0.5 million greater headwind than in the same period a year ago. The benefit of higher sales volumes was more than offset by higher LIFO and freight costs.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative (“SG&A”) expenses increased $4.3 million, or 14%, to $35.3 million, or 11% of sales, for the current quarter, from $31.0 million, or 11% of sales, in the same period a year ago. This included $2.1 million due to added costs from the acquired businesses in our Water Treatment segment. In addition, the prior-year period included a $1.9 million favorable fair value adjustment that reduced SG&A, reflecting a downward revision to the estimated Water Solutions earnout liability based on a change in projected estimates related to the earnout target. This benefit did not recur in the current period, resulting in a $1.9 million year-over-year increase in SG&A. SG&A also included a $0.5 million incremental increase in non-qualified deferred compensation expense, which was offset by a corresponding gain within other income. These increases were partially offset by lower acquisition-related costs and other changes across our operating expenses.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended June 28, 2026 was $56.9 million, an increase of $0.8 million, or 1%, from $56.1 million in the same period a year ago. In the third quarter of fiscal 2026, we revised our definition of adjusted EBITDA to exclude non-cash earnout related expense and income, in order to better reflect results from operations. Prior-year adjusted EBITDA has been recast in accordance with the current definition. As originally reported, adjusted EBITDA for the three months ended June 29, 2025 was $57.6 million, which included non-cash earnout related income that is excluded under the current definition.

INCOME TAXES

Our effective income tax rate was 24% for the current quarter and 25% for the same period a year ago. The effective tax rate in both years was impacted by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is expected to be approximately 25% to 27%.

Financial statements

Income Statement

Adjusted EBITDA (in thousands)

Three months ended – June 28, 2026Three months ended – June 29, 2025Trailing twelve months ended – June 28, 2026Trailing twelve months ended – June 29, 2025
Net Income (GAAP)28,25429,17580,62784,641
Interest expense, net2,7733,26913,0117,438
Income tax expense9,0709,83127,03130,061
Amortization of intangibles5,5164,82121,98714,783
Depreciation expense8,4297,47032,20928,127
Non-cash compensation expense2,2352,2128,5967,243
Non-recurring acquisition expenses (1)638704321,911
Non-cash earnout related expense (income)535-1,583-4,059-553
Adjusted EBITDA56,87556,065179,834173,651

Income Statement

Three months ended — (In thousands, except share and per-share data)

Three months ended – June 28, 2026Three months ended – June 29, 2025
Sales315,675293,272
Cost of sales-241,668-220,910
Gross profit74,00772,362
Selling, general and administrative expenses-35,335-31,029
Operating income38,67241,333
Interest expense, net-2,773-3,269
Other income1,425942
Income before income taxes37,32439,006
Income tax expense-9,070-9,831
Net income28,25429,175
Weighted average number of shares outstanding - basic20,777,48120,717,485
Weighted average number of shares outstanding - diluted20,853,99120,810,562
Basic earnings per share1.361.41
Diluted earnings per share1.351.4
Cash dividends declared per common share0.190.18

Income Statement

Water Treatment — (In thousands) (in thousands)

Three months ended June 28, 2026: – Water TreatmentThree months ended June 28, 2026: – Food & Health SciencesThree months ended June 28, 2026: – Industrial SolutionsThree months ended June 28, 2026: – Total
Sales158,29397,25060,132315,675
Cost of sales - materials-94,481-73,345-47,858-215,684
Cost of sales - operational overhead-18,316-4,630-3,038-25,984
Gross profit45,49619,2759,23674,007
Selling, general, and administrative expenses-23,670-8,028-3,637-35,335
Operating income21,82611,2475,59938,672
Three months ended June 29, 2025:Sales149,56689,17754,529293,272
Three months ended June 29, 2025:Cost of sales - materials-89,159-65,814-42,848-197,821
Three months ended June 29, 2025:Cost of sales - operational overhead-16,660-4,015-2,414-23,089
Three months ended June 29, 2025:Gross profit43,74719,3489,26772,362
Three months ended June 29, 2025:Selling, general, and administrative expenses-19,085-8,381-3,563-31,029
Three months ended June 29, 2025:Operating income24,66210,9675,70441,333

Balance Sheet

(In thousands, except share data)

June 28, 2026March 29, 2026
CURRENT ASSETS:Cash and cash equivalents7,9773,914
CURRENT ASSETS:Trade accounts receivables, net151,773139,796
CURRENT ASSETS:Inventories79,86478,199
CURRENT ASSETS:Prepaid expenses and other current assets9,1659,556
CURRENT ASSETS:Total current assets248,779231,465
CURRENT ASSETS:Property, plant, and equipment501,792489,662
CURRENT ASSETS:Less accumulated depreciation231,206223,406
CURRENT ASSETS:Net property, plant, and equipment270,586266,256
OTHER ASSETS:Right-of-use assets16,08116,840
OTHER ASSETS:Goodwill223,828223,042
OTHER ASSETS:Intangible assets, net229,018232,887
OTHER ASSETS:Deferred compensation plan asset16,47712,812
OTHER ASSETS:Other1,4742,988
OTHER ASSETS:Total other assets486,878488,569
OTHER ASSETS:Total assets1,006,243986,290
CURRENT LIABILITIES:Accounts payable — trade62,84559,835
CURRENT LIABILITIES:Accrued payroll and employee benefits15,75020,092
CURRENT LIABILITIES:Income tax payable8,23698
CURRENT LIABILITIES:Environmental remediation7,7007,700
CURRENT LIABILITIES:Other current liabilities (Note 8)15,08317,119
CURRENT LIABILITIES:Total current liabilities109,614104,844
LONG-TERM LIABILITIES:Long-term debt244,000244,000
LONG-TERM LIABILITIES:Long-term lease liabilities13,70314,457
LONG-TERM LIABILITIES:Pension withdrawal liability2,6632,763
LONG-TERM LIABILITIES:Deferred income taxes25,06525,110
LONG-TERM LIABILITIES:Deferred compensation liability17,33014,850
LONG-TERM LIABILITIES:Earnout liabilities45,43344,898
LONG-TERM LIABILITIES:Other long-term liabilities2311,359
LONG-TERM LIABILITIES:Total long-term liabilities348,425347,437
LONG-TERM LIABILITIES:Total liabilities458,039452,281
SHAREHOLDERS' EQUITY:Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,743,884 and 20,752,138 shares issued and outstanding as of June 28, 2026 and March 29, 2026, respectively207208
SHAREHOLDERS' EQUITY:Additional paid-in capital22,75032,678
SHAREHOLDERS' EQUITY:Retained earnings524,425500,142
SHAREHOLDERS' EQUITY:Accumulated other comprehensive income822981
SHAREHOLDERS' EQUITY:Total shareholders’ equity548,204534,009
SHAREHOLDERS' EQUITY:Total liabilities and shareholders’ equity1,006,243986,290

Cash Flow

Free Cash Flow Reconciliation (in thousands)

Three months ended – June 28, 2026Three months ended – June 29, 2025
Net cash provided by operating activities35,15231,490
Less: Purchases of property, plant & equipment-11,605-13,544
Free cash flow23,54717,946

Cash Flow

Three months ended — (In thousands) (in thousands)

Three months ended – June 28, 2026Three months ended – June 29, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:Net income28,25429,175

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Hawkins earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.